How to get your kids to sleep earlier and better, and the signs of sleep deprivation
Advertisement
Research shows that today's teenagers are more sleep-deprived than ever before. Adolescents need between eight and 10 hours of sleep, according to the US Centres for Disease Control and Prevention.
But nearly 80 per cent of American teenagers are not getting that, and experts say it is affecting important areas like mental health and school attendance.
Bedtime routines are not just for toddlers. Teenagers need them too, says Denise Pope, an expert on child development and a senior lecturer at Stanford University's Graduate School of Education, in the US state of California.
Experts in adolescent sleep say a few small changes to how parents and teens approach sleep can make a dramatic difference. Here is their advice.
The best sleep environment is a cool, dark, quiet room without electronic devices. Photo: Shutterstock
1. A tech-free bedtime routine for teens
The first step to setting up a better bedtime routine is dealing with technology.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
AllAfrica
21-07-2025
- AllAfrica
FDA flags breakdowns at Indian pharma factory exporting to the US
This article was originally published by ProPublica, a Pulitzer Prize-winning investigative newsroom. US inspectors have uncovered new and dangerous breakdowns in drugmaking at an Indian factory owned by Sun Pharma that produces generic medications for American consumers. The latest problems come 2 1/2 years after the Food and Drug Administration gave the facility a special pass to continue sending certain drugs made there to the United States, even after the factory was officially banned from the US market. The factory failed to investigate the source of bacteria found in test vials or deal with damaged equipment that had caused drugs to be contaminated with metal particles, according to the June inspection report, which ProPublica obtained through a Freedom of Information Act request. Workers improperly handled vials and stoppers meant for sterile medications and, in some cases, failed to disinfect manufacturing areas and equipment, according to the report. One FDA inspector saw a worker put on a sterile gown and then brush up against a waste bin and use their hands to push down the overflowing trash. Investigators also saw liquid dripping through ceiling cracks and the growth of what appeared to be fungus and mold in a storage area for samples used for testing. The FDA in late 2022 had banned the factory in the city of Halol from shipping drugs to the United States because of similar manufacturing failures. ProPublica reported last month that a low-profile group inside the agency at the same time exempted some medications from that ban, ostensibly to prevent drug shortages. The FDA has granted similar exemptions for drugs made at more than 20 other foreign factories that violated critical standards in drugmaking and were barred from the US market. The FDA kept the practice largely hidden from the public. The agency did not regularly test drugs coming from the banned factories or proactively monitor reports about potential harm among consumers, ProPublica found. In Sun's case, more than a dozen drugs were initially excluded from the Halol import ban. The company is still allowed to send five to the United States, government records show, including vecuronium bromide, a muscle relaxer used during surgery, and the cancer drug doxorubicin. Also excluded are divalproex delayed release tablets, which treat seizures and other conditions; leuprolide injection, used by people with prostate cancer, endometriosis and other conditions; and temozolomide capsules, for brain cancer. The inspection last month marked the first time the FDA had been back to the factory in the 2.5 years since it imposed the import ban and Sun started sending exempted drugs to the United States. Inspectors found that procedures designed to prevent microbiological contamination of sterile drugs were not established or followed and that equipment wasn't maintained to prevent malfunctions that would 'alter the safety, identity, strength, quality or purity of the drug product,' according to the report. Some of the concerns focused on the exempted drugs still being sent to the United States, according to a person familiar with the situation who did not want to be named because they were not authorized to speak publicly. The FDA blacked out the names of the drugs that were potentially compromised on its publicly released inspection report, including a medication made on a manufacturing line in which several batches had to be rejected because they were filled with black particles. 'It's disappointing to see issues continue to come up at this site given the site's role in potentially manufacturing critical drugs for US consumers,' said the person familiar with the inspection findings. Sun did not respond to questions about the latest inspection or its regulatory history with the FDA. In an email, the company said that adherence to quality standards 'is a top priority for Sun, and we maintain a relentless focus on quality and compliance to ensure the uninterrupted supply of medicines to our customers and patients worldwide. We continue to work proactively with the US FDA and remain committed to achieve full resolution of any FDA regulatory issues at our facilities.' The FDA said factories that receive exemptions from import bans are required to conduct extra testing on drugs with third-party oversight before they are sent to the United States, helping to ensure patient safety. Sun's Halol plant, however, was cited in 2022 and again last month for failing to thoroughly investigate unexplained quality problems, including impurities, found during drug testing. The FDA did not respond to a request for comment about the latest Sun inspection. US Rep. Debbie Dingell, D-Michigan, who recently co-sponsored a bill to lower prescription drug costs, said in a statement to ProPublica that the FDA has a responsibility to ensure that drugs coming into the country are safe. 'We need full transparency about the extent to which exemptions enabled sub-par, unsafe, or ineffective drugs to be distributed to American patients,' she said. Medill Investigative Lab student Katherine Dailey contributed reporting . Sign up to receive ProPublica's biggest stories as soon as they're published.
RTHK
08-07-2025
- RTHK
Kennedy hit by legal blowback over Covid vaccine move
Kennedy hit by legal blowback over Covid vaccine move US Health Secretary Robert F Kennedy Jr has worked to overhaul American vaccination policies since taking office. File photo: Reuters Several leading medical groups have filed suit against US Health Secretary Robert F Kennedy Jr, accusing him of endangering public health with new Covid-19 vaccine recommendations. At the end of May, Kennedy announced via social media that federal authorities would no longer recommend Covid-19 vaccines for children and those who are pregnant, resulting in blowback from health experts. In the lawsuit, the American Academy of Pediatrics, the American College of Physicians and other leading medical groups are calling on the court to stop Kennedy's "unilateral, unscientific" directive and restore Covid-19 vaccines to immunisation schedules. "It is really unconscionable to take away a parent's ability and choice to protect their children through vaccination," said Tina Tan, a pediatrician and president of the Infectious Diseases Society of America, one of the plaintiffs. Since taking office, Kennedy – who spent decades spreading vaccine misinformation before becoming US President Donald Trump's top health official – has worked to overhaul American vaccination policies. In June, he fired all 17 members of the Advisory Committee on Immunisation Practices and appointed his own panelists, under the banner of "Make America Healthy Again". Monday's complaint also highlighted the controversial new appointees to the advisory committee. "We are on a dangerous path," warned Susan Kressly of the American Academy of Pediatrics, denouncing what she described as misinformation spread by Kennedy while citing the concerns of her peers and parents of patients. "Pediatricians cannot stay silent as the system we rely on to support life-saving vaccines is chiseled away piece by piece, with Secretary Kennedy leading efforts to sow doubt and distrust in the American success story of vaccines," Kressly said. The problem isn't limited to parents and children, as misinformation about vaccines undermines a long-standing trust between doctor and patient. Increasingly, medical professionals are finding that adult patients are "hesitant to get their vaccines. They are not trusting the system anymore," said Jason Goldman, president of the American College of Physicians. The issue of vaccines extends beyond Covid-19 in the United States. Johns Hopkins University released a count on Monday finding the US has recorded its worst measles epidemic in more than 30 years, with 1,277 cases confirmed since the beginning of 2025, and illness recorded in 40 of 50 states. The nationwide figure is the highest since 1992. (AFP)
South China Morning Post
29-04-2025
- South China Morning Post
Hong Kong's Li Ka-shing appears in person for first time since Hutchison ports deal
Hong Kong tycoon Li Ka-shing has made his first in-person public appearance since controversy erupted over his conglomerate's sale of its overseas ports to a consortium led by American investment firm BlackRock amid the US-China trade war, a deal that has drawn Beijing's ire. Advertisement The founder of CK Hutchison Holdings visited Hong Kong Sanatorium & Hospital (HKSH) in Happy Valley on Tuesday to observe a demonstration of a cutting-edge, non-invasive device donated by the Li Ka Shing Foundation for treating liver cancer. '[The hospital] providing this option is definitely great news,' Li said. The 'Histotripsy 2.0' system was delivered to the hospital this month. The 96-year-old tycoon, nicknamed 'Superman' for his business acumen and influence, appeared energetic and joyful, grinning while shaking hands with Walton Li Wai-tat, CEO of HKSH Medical Group and medical superintendent of the hospital.
